This is the supplier profile page of 广东哆比生物科技有限公司, where buyers can explore products, connect directly with the supplier for pricing inquiries.
Vietnam
2.6
Building 1, No. 14
34 inquiries
Add Favorite
|
Report Supplier
|
Business Description
Trade Capabilities
Business Terms
Preferred Payment Term:
Not specified
Preferred Trade Term:
Not specified
Port Of Loading:
Not specified
Accepted Currency:
USD
Trade Ability
Annual Revenue Amount:
Annual revenue of USD 100M~500M
Numbers Of Employees:
100-499
Avg Response Time:
-
In international trade, USD is widely accepted and often preferred for its stability and global recognition. For Guangdong Dobibio Biotech Co., Ltd., accepting USD simplifies transactions with buyers in North America and Europe. The lack of specified payment terms, Incoterms, and port of shipment means buyers must confirm these details before proceeding — this can delay orders or increase risk if not clearly defined. With 100-499 employees and an annual turnover of 100-500, Guangdong Dobibi Biotechnology Co., Ltd. is a mid-sized player with the scale to handle consistent orders and offer reliable service. The lack of accreditation details and unclear inquiry response time raises questions about their compliance and customer service reliability — buyers should verify these aspects before committing to long-term partnerships.
Products / Services Offered
Offering candy, filled candy, and pudding allows广东哆比生物科技有限公司 to provide ready-to-eat, shelf-stable products that skip the need for complex food preparation by buyers. This reduces buyer logistics and storage costs. Buyers can expect consistent quality and packaging options without needing to source multiple suppliers for different product types.
Supplier Verified
Verify work email
Verify phone number
Verify account email
广东哆比生物科技有限公司 has verified work email and phone, which helps buyers confirm direct contact and respond quickly to inquiries. The lack of document verification means buyers should request additional business documents before placing large orders. Verified account email adds a layer of trust in the company's legitimacy.
Export Countries
China
Indonesia
East Asia
50%
Southeast Asia
50%
广东哆比生物科技有限公司 operates in 2 countries across 2 regions, with equal exposure to East Asia and Southeast Asia at 50% each. China accounts for 50% of its market footprint, while Indonesia makes up the remaining 50%. This balanced regional approach reflects a strategic focus on key emerging biotech markets within Asia, enabling access to both high-growth and established regulatory environments.
